Top

International Journal of Colorectal Disease

Published in:

01-09-2005 | Original Article

Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy

Authors: Rodrigo Oliva Perez, Angelita Habr-Gama, Sidney Tomyo Nishida Arazawa, Viviane Rawet, Sheila Aparecida Coelho Siqueira, Desidério Roberto Kiss, Joaquim José Gama-Rodrigues

Published in: International Journal of Colorectal Disease | Issue 5/2005

Abstract

Objective

The objective was to determine the presence and frequency of micrometastasis in lymph nodes of patients with rectal cancer treated by preoperative chemoradiation followed by curative resection.

Patients and methods

All 56 patients included were treated with 5-FU and leucovorin plus 5,040 cGy, followed by radical surgery and were diagnosed with stage II distal rectal adenocarcinoma after complete pathological examination (ypT3-4N0M0). Immunohistochemistry was assessed with cytokeratin monoclonal antibody AE1/AE3. Three 4-μm paraffin sections were obtained from each lymph node, cut at 50 μm apart from each other. The results were reviewed by two independent pathologists.

Results

Mean number of lymph nodes was 9.6 per patient. Four patients (7%) and seven lymph nodes (1.35%) were positive for micrometastasis. Three patients had pT3 and one a pT4 tumor. One of the patients had positive micrometastasis and the presence of mucinous deposits. One other patient had mucinous deposits without any micrometastasis. All four patients are alive with no evidence of recurrent disease. Fourteen patients negative for micrometastasis had recurrent disease (25%), eight systemic (14.7%) and six locoregional (10.3%). There were two cancer-related deaths. The mean follow-up period was 39 months.

Conclusion

Patients with rectal cancer treated by preoperative chemoradiation showed a surprisingly low rate of micrometastasis detection (7%), even in high-risk patients (T3 and T4 tumors). Lymph node micrometastasis was not associated with decreased overall or disease-free survival. The identification of mucinous deposits on lymph nodes with no viable tumor cells may be direct evidence of lymph node downstaging. The downstaging effect of preoperative chemoradiation therapy may be significant in reducing even micrometastasis detection in low rectal cancer managed by this treatment strategy.

Lopez MJ, Monafo WW (1993) Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. Surgery 113:365–372PubMed

Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, Miedema B, Ota D, Sargent D, National Cancer Institute Expert Panel (2001) Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93:583–596

Adachi Y, Mori M, Matsushima T, Kido A, Shimono R, Inoue T, Sugimachi K (1994) The distribution of lymph node metastases in right-sided colon cancer. J Clin Gastroenterol 19:210–213

Willett CG, Tepper JE, Kaufman DS, Shellito PC, Eliseo R, Convery K, Wood WC (1992) Adjuvant postoperative radiation therapy for rectal adenocarcinoma. Am J Clin Oncol 15:371–375

Schild SE, Martenson JA Jr, Gunderson LL, Ilstrup DM, Berg KK, O’Connell MJ, Weiland LH (1989) Postoperative adjuvant therapy of rectal cancer: an analysis of disease control, survival, and prognostic factors. Int J Radiat Oncol Biol Phys 17:55–62

Vigliotti A, Rich TA, Romsdahl MM, Withers HR, Oswald MJ (1987) Postoperative adjuvant radiotherapy for adenocarcinoma of the rectum and rectosigmoid. Int J Radiat Oncol Biol Phys 13:999–1006

Noura S, Yamamoto H, Miyake Y, Kim B, Takayama O, Seshimo I, Ikenaga M, Ikeda M, Sekimoto M, Matsuura N, Monden M (2002) Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer. Clin Cancer Res 8:759–767

Pelkey TJ, Frierson HF Jr, Bruns DE (1996) Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 42:1369–1381PubMed

Noura S, Yamamoto H, Ohnishi T, Masuda N, Matsumoto T, Takayama O et al (2002) Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol 20:4232–4241CrossRefPubMed

10.

Gunn J, McCall JL, Yun K, Wright PA (1996) Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction. Lab Invest 75:611–616PubMed

11.

Cutait R, Alves VA, Lopes LC, Cutait DE, Borges JL, Singer J, da Silva JH, Goffi FS (1991) Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 34:917–920PubMed

12.

Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr (1994) Identification of occult micrometastases in pericolic lymph nodes of Duke’s B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 73:563–569PubMed

13.

Nicholson AG, Marks CG, Cook MG (1994) Effect on lymph node status of triple levelling and immunohistochemistry with CAM 5.2 on node negative colorectal carcinomas. Gut 35:1447–1448PubMed

14.

Adell G, Boeryd B, Franlund B, Sjodahl R, Hakansson L (1996) Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes’ B colorectal carcinoma: an immunohistochemical study. Eur J Surg 162:637–642PubMed

15.

Sasaki M, Watanabe H, Jass JR, Ajioka Y, Kobayashi M, Matsuda K, Hatakeyama K (1997) Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in “node-negative” colorectal cancer. J Gastroenterol 32:758–764PubMed

16.

Oberg A, Stenling R, Tavelin B, Lindmark G (1998) Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum 41:1244–1249PubMed

17.

Isaka N, Nozue M, Doy M, Fukao K (1999) Prognostic significance of perirectal lymph node micrometastases in Dukes’ B rectal carcinoma: an immunohistochemical study by CAM5.2. Clin Cancer Res 5:2065–2068

18.

Yasuda K, Adachi Y, Shiraishi N, Yamaguchi K, Hirabayashi Y, Kitano S (2001) Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol 8:300–304PubMed

19.

Haboubi NY, Clark P, Kaftan SM, Schofield PF (1992) The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. J R Soc Med 85:386–388PubMed

20.

Miyake Y, Yamamoto H, Fujiwara Y, Ohue M, Sugita Y, Tomita N et al (2001) Extensive micrometastases to lymph nodes as a marker for rapid recurrence of colorectal cancer: a study of lymphatic mapping. Clin Cancer Res 7:1350–1357PubMed

21.

Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, Tollenaar RA (1998) Micrometastases and survival in stage II colorectal cancer. N Engl J Med 339:223–228CrossRefPubMed

22.

Aleman BM, Bartelink H, Gunderson LL (1995) The current role of radiotherapy in colorectal cancer. Eur J Cancer 31A:1333–1339

23.

Enker WE, Paty PB, Minsky BD, Cohen AM (1992) Restorative or preservative operations in the treatment of rectal cancer. Surg Oncol Clin N Am 1:57–69

24.

Marks G, Mohiuddin M, Masoni L, Montori A (1992) High-dose preoperative radiation therapy as the key to extending sphincter-preservation surgery for cancer of the distal rectum. Surg Oncol Clin N Am 1:71–86

25.

Habr-Gama A, de Souza PM, Ribeiro U Jr, Nadalin W, Gansl R, Sousa AH Jr, Campos FG, Gama-Rodrigues J (1998) Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 41:1087–1096PubMed

26.

Habr-Gama A, Perez RO, Kiss DR, Rawet V, Scanavini A, Santinho PM, Nadalin W (2004) Preoperative chemoradiation therapy for low rectal cancer—impact on downstaging and sphincter-saving operations. Hepatogastroenterology 51:1703–1707

27.

Wichmann MW, Muller C, Meyer G, Strauss T, Hornung HM, Lau-Werner U, Angele MK, Schildberg FW (2002) Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg 137:206–210

28.

Bedrosian I, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, Vauthey JN, Delclos M, Crane C, Janjan N, Skibber JM (2004) Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg 8:56–63; discussion 62–53

29.

Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240:711–717; discussion 717–718

30.

Jeffers MD, O’Dowd GM, Mulcahy H, Stagg M, O’Donoghue DP, Toner M (1994) The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 172:183–187PubMed

31.

Fielding P (1995) Staging systems. In: Cohen A, Winawer S (eds) Cancer of the colon, rectum and anus. McGraw-Hill, New York, p 207

32.

O’Connell MJ, Mailliard JA, Kahn MJ, Macdonald JS, Haller DG, Mayer RJ, Wieand HS (1997) Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 15:246–250PubMed

33.

Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ et al (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352–358PubMed

34.

Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG et al (2002) Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg 194:131–135; discussion 135–136CrossRefPubMed

Title: Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy
Authors: Rodrigo Oliva Perez
Angelita Habr-Gama
Sidney Tomyo Nishida Arazawa
Viviane Rawet
Sheila Aparecida Coelho Siqueira
Desidério Roberto Kiss
Joaquim José Gama-Rodrigues
Publication date: 01-09-2005
Publisher: Springer-Verlag
Published in: International Journal of Colorectal Disease / Issue 5/2005
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-004-0712-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy

Abstract

Objective

Patients and methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Patients and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2005

Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma

Double frameshift mutations in APC and MSH2 in the same individual

Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study

IgA nephropathy in association with Crohn’s disease

Modified lay-open (incision, curettage, partial lateral wall excision and marsupialization) versus total excision with primary closure in the treatment of chronic sacrococcygeal pilonidal sinus

Perirectal haematoma and hypovolaemic shock after rectal stapled mucosectomy for haemorrhoids